IMPACT OF INTRACORONARY ADMINISTRATION OF NITROPRUSSIDE VS. NITROGLYCERINE BEFORE BALLOON DILATATION ON SLOW REFLOW DURING PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE ST ELEVATION MYOCARDIAL INFARCTION

被引：1
|
作者：
Sai, Sudhakar [1 ]
Fischer, L. [1 ]
Shivkumar, J. [1 ]
Shivkumar, J. [1 ]
Vishnuarunachalam, R. [1 ]
机构：
[1] Apollo Hosp Secunderabad, Secunderabad, India
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 57卷 / 14期
关键词：
D O I：
10.1016/S0735-1097(11)60988-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E988 / E988
页数：1
相关论文
共 50 条
  • [31] Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction
    Legutko, Jacek
    Siudak, Zbigniew
    Dudek, Dariusz
    Rzeszutko, Lukasz
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (12): : 1314 - 1314
  • [32] Thrombectomy During Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction
    Thakkar, Samarthkumar
    Nair, Ambica
    Desai, Parth
    Arora, Shilpkumar
    Zaid, Syed
    Aoun, Joe
    Goel, Sachin
    Kleiman, Neal
    Shah, Alpesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B398 - B399
  • [33] Effect of empagliflozin on no-reflow in patients with st elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Nasef, M. A.
    Saber, M.
    Gomaa, Y.
    Kamal, D.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis
    Niu, Xiaowei
    Zhang, Jingjing
    Bai, Ming
    Peng, Yu
    Sun, Shaobo
    Zhang, Zheng
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [35] Direct intracoronary delivery of tirofiban during primary percutaneous coronary intervention for ST-elevation myocardial infarction
    SHEN Wei-feng Department of Cardiology
    中华医学杂志（英文版）, 2012, (01) : 3 - 6
  • [36] Direct intracoronary delivery of tirofiban during primary percutaneous coronary intervention for ST-elevation myocardial infarction
    Shen Wei-feng
    CHINESE MEDICAL JOURNAL, 2012, 125 (01) : 3 - 6
  • [37] Abciximab During Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Intracoronary, Intravenous, or Not at All?
    Bittl, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (13) : 1455 - 1457
  • [38] Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction
    Eitel, Ingo
    Desch, Steffen
    Schindler, Kathrin
    Fuernau, Georg
    Schuler, Gerhard
    Thiele, Holger
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (01) : 21 - 25
  • [39] Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis
    Xiaowei Niu
    Jingjing Zhang
    Ming Bai
    Yu Peng
    Shaobo Sun
    Zheng Zhang
    BMC Cardiovascular Disorders, 18
  • [40] Effect of Intracoronary Anisodamine and Diltiazem Administration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
    Peng Yuhong
    Wei, L.
    Geng, Wei
    Xing, Kun
    Ru, Leisheng
    Sun, Jiaan
    Zhao, Yuying
    Fu, Xianghua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C130 - C130
12345